Rhumbline Advisers Regeneron Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 174,746 shares of REGN stock, worth $129 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
174,746
Previous 180,097 2.97%
Holding current value
$129 Million
Previous $189 Million 2.95%
% of portfolio
0.17%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $5.48 Million - $6.43 Million
-5,351 Reduced 2.97%
174,746 $184 Million
Q2 2024

Aug 01, 2024
SELL
$883.2 - $1071.19 $3.06 Million - $3.72 Million
-3,470 Reduced 1.89%
180,097 $189 Million
Q1 2024

May 09, 2024
BUY
$902.69 - $993.35 $1.78 Million - $1.96 Million
1,969 Added 1.08%
183,567 $177 Million
Q4 2023

Feb 08, 2024
SELL
$775.18 - $881.7 $1.3 Million - $1.48 Million
-1,680 Reduced 0.92%
181,598 $159 Million
Q3 2023

Nov 09, 2023
SELL
$692.45 - $844.37 $1.94 Million - $2.36 Million
-2,795 Reduced 1.5%
183,278 $151 Million
Q2 2023

Aug 08, 2023
BUY
$700.03 - $830.35 $1.66 Million - $1.97 Million
2,369 Added 1.29%
186,073 $134 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $2.86 Million - $3.47 Million
-4,201 Reduced 2.24%
183,704 $151 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $6.29 Million - $6.83 Million
8,907 Added 4.98%
187,905 $136 Million
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $3.11 Million - $3.93 Million
5,425 Added 3.13%
178,998 $123 Million
Q2 2022

Aug 11, 2022
BUY
$548.35 - $738.84 $5.73 Million - $7.72 Million
10,447 Added 6.4%
173,573 $103 Million
Q1 2022

May 12, 2022
BUY
$595.12 - $698.43 $670,700 - $787,130
1,127 Added 0.7%
163,126 $114 Million
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $397,827 - $491,150
732 Added 0.45%
161,999 $102 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $301,365 - $357,504
-525 Reduced 0.32%
161,267 $97.6 Million
Q2 2021

Aug 05, 2021
SELL
$472.8 - $558.54 $1.63 Million - $1.93 Million
-3,458 Reduced 2.09%
161,792 $90.4 Million
Q1 2021

May 06, 2021
SELL
$446.73 - $548.2 $3.85 Million - $4.73 Million
-8,624 Reduced 4.96%
165,250 $78.2 Million
Q4 2020

Feb 10, 2021
SELL
$478.3 - $607.98 $9.09 Million - $11.6 Million
-19,004 Reduced 9.85%
173,874 $84 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $1.64 Million - $1.99 Million
-3,019 Reduced 1.54%
192,878 $108 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $24.4 Million - $31.8 Million
49,448 Added 33.76%
195,897 $122 Million
Q1 2020

May 06, 2020
BUY
$336.18 - $494.43 $130,101 - $191,344
387 Added 0.26%
146,449 $71.5 Million
Q4 2019

Feb 05, 2020
BUY
$274.13 - $376.51 $1.26 Million - $1.72 Million
4,581 Added 3.24%
146,062 $54.8 Million
Q3 2019

Oct 23, 2019
BUY
$273.46 - $318.39 $1.74 Million - $2.03 Million
6,372 Added 4.72%
141,481 $39.2 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $685,784 - $949,522
2,289 Added 1.72%
135,109 $42.3 Million
Q1 2019

May 01, 2019
SELL
$372.08 - $439.57 $5.36 Million - $6.34 Million
-14,415 Reduced 9.79%
132,820 $54.5 Million
Q4 2018

Jan 31, 2019
BUY
$335.82 - $403.04 $370,745 - $444,956
1,104 Added 0.76%
147,235 $55 Million
Q3 2018

Nov 07, 2018
SELL
$351.14 - $408.51 $469,825 - $546,586
-1,338 Reduced 0.91%
146,131 $59 Million
Q2 2018

Aug 06, 2018
BUY
$284.6 - $344.99 $1.17 Million - $1.41 Million
4,098 Added 2.86%
147,469 $50.9 Million
Q1 2018

May 02, 2018
BUY
$315.82 - $393.78 $46,741 - $58,279
148 Added 0.1%
143,371 $49.4 Million
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $2.85 Million - $3.73 Million
7,939 Added 5.87%
143,223 $53.8 Million
Q3 2017

Nov 06, 2017
BUY
$431.38 - $504.0 $58.4 Million - $68.2 Million
135,284
135,284 $60.5 Million

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email